Repealing the Trump Sick Tax Act

This bill repeals two specific provisions from the 2023 "Trump Sick Tax Act" (Public Law 119-21) that affected Medicaid and drug pricing. It restores previous Medicaid cost-sharing rules under Title XIX of the Social Security Act and reverts changes to orphan drug exclusions under the Drug Price Negotiation Program (Title XI). These changes directly affect Medicaid beneficiaries and pharmaceutical manufacturers by returning to the pre-2023 policy framework for cost-sharing and drug pricing negotiations. The bill does not create new programs but reverses specific cost-related provisions enacted in 2023.